---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-22-014518"
form_type: "8-K"
ticker: "BLGO"
cik: "0000880242"
company_name: "BIOLARGO, INC."
filed_at: "2022-06-07T23:59:59+00:00"
generated_at: "2026-06-25T04:09:01.978675+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# BioLargo shareholders approve increase in authorized shares to 550M and authorize reverse stock split

## Summary
- Authorized common shares increased from 400M to 550M, effective June 7, 2022.
- Board authorized to implement a reverse stock split at a ratio between 1:4 and 1:25 at its discretion.
- All seven director nominees elected; advisory say-on-pay passed with 84.3M for, 9.8M against.
- Ratification of Haskell & White LLP as auditor for FY2022 approved with 151.2M for.
- Reverse split proposal passed with 136.2M for, 16.7M against.

## SEC filing metadata
- accession: 0001437749-22-014518
- form_type: 8-K
- ticker: BLGO
- cik: 0000880242
- company_name: BIOLARGO, INC.
- filed_at: 2022-06-07T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.03, 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/880242/000143774922014518/0001437749-22-014518-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/880242/000143774922014518/blgo20220606_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-22-014518
- JSON: https://secwatch.observer/filing/0001437749-22-014518.json
- Plain text: https://secwatch.observer/filing/0001437749-22-014518.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.